Avadel Pharmaceuticals (AVDL) Other Non Operating Income: 2009-2020
Historic Other Non Operating Income for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Jun 2020 value amounting to -$125,000.
- Avadel Pharmaceuticals' Other Non Operating Income fell 150.00% to -$125,000 in Q2 2020 from the same period last year, while for Jun 2020 it was -$456,000, marking a year-over-year decrease of 185.23%. This contributed to the annual value of -$435,000 for FY2020, which is 15.08% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Other Non Operating Income of -$125,000 as of Q2 2020, which was up 59.68% from -$310,000 recorded in Q1 2020.
- Avadel Pharmaceuticals' Other Non Operating Income's 5-year high stood at $1.7 million during Q2 2017, with a 5-year trough of -$2.9 million in Q1 2016.
- Over the past 3 years, Avadel Pharmaceuticals' median Other Non Operating Income value was -$87,500 (recorded in 2019), while the average stood at $108,600.
- In the last 5 years, Avadel Pharmaceuticals' Other Non Operating Income skyrocketed by 160.22% in 2017 and then plummeted by 171.82% in 2018.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Other Non Operating Income stood at -$413,000 in 2016, then crashed by 122.03% to -$917,000 in 2017, then soared by 150.93% to $467,000 in 2018, then slumped by 74.73% to $118,000 in 2019, then slumped by 150.00% to -$125,000 in 2020.
- Its Other Non Operating Income stands at -$125,000 for Q2 2020, versus -$310,000 for Q1 2020 and $118,000 for Q4 2019.